Description |
1 online resource |
Contents |
Preface; Contents; 1: Primary Central Nervous System Lymphomas; 1.1 Introduction; 1.2 Pathology; 1.3 Pretreatment Evaluation; 1.4 Treatment Strategy; 1.5 Chemotherapy; 1.6 Radiation Therapy (Indications); 1.6.1 Consolidation RT in Patients with CR After Chemotherapy; 1.6.2 RT for Refractory or Recurrent PCNSL After Chemotherapy Alone; 1.6.3 RT for Progressive Disease During Initial Chemotherapy; 1.6.4 Re-irradiation for Recurrence After Whole-Brain Radiotherapy; 1.6.5 Palliative RT; 1.6.6 RT in Elderly Patients; 1.6.7 Radiotherapy for Intraocular Involvement by PCNSL |
|
1.6.8 RT for Primary Intraocular Lymphoma1.7 Radiation Therapy (Treatment Procedures); 1.7.1 RT Planning; 1.7.2 Whole-Brain Radiotherapy (Fig. 1.2); 1.7.2.1 Target Volumes; 1.7.2.2 Radiation Field; 1.7.2.3 Beam Energy; 1.7.2.4 Dose and Fractionation; 1.7.3 Partial Brain RT (Fig. 1.3); 1.7.3.1 Target Volumes; 1.7.3.2 RT Technique; 1.7.3.3 Dose; 1.8 Outcomes; 1.8.1 Survival; 1.8.2 Prognostic Factors; 1.9 Toxicity; 1.9.1 Acute Toxicity; 1.9.2 Late Toxicity; References; 2: Ocular Adnexal Lymphoma; 2.1 Introduction; 2.2 Pathology, Immunophenotype, and Cytogenetic Abnormalities |
|
2.2.1 MALT Lymphoma2.3 Clinical Features; 2.3.1 MALT Lymphoma; 2.3.2 DLBCL; 2.4 Pretreatment Evaluation and Staging; 2.5 Prognostic Factors; 2.6 Treatment Strategy; 2.6.1 MALT Lymphoma; 2.6.2 Diffuse Large B-Cell Lymphoma; 2.7 Radiation Therapy; 2.7.1 Clinical Target Volume; 2.7.1.1 MALT Lymphoma and Other Indolent Lymphomas; 2.7.1.2 DLBCL and Other Aggressive Lymphomas; 2.7.2 Dose; 2.7.2.1 MALT Lymphoma and Other Indolent Lymphomas; 2.7.2.2 DLBCL; 2.7.3 Radiation Therapy Techniques; 2.8 Outcomes; 2.8.1 MALT Lymphoma; 2.8.1.1 Response |
|
2.8.1.2 Survival and Disease Progression2.8.2 Diffuse Large B-Cell Lymphoma; 2.9 Toxicity; 2.10 Summary; References; 3: Extranodal NK/T Cell Lymphoma, Nasal Type; 3.1 Introduction; 3.2 Pathology; 3.3 Pretreatment Evaluation and Prognostic factors; 3.4 Treatment Strategy; 3.5 Chemotherapy; 3.6 Radiation Therapy (Indications); 3.7 Radiation Therapy (Treatment Procedures); 3.7.1 RT Planning; 3.7.2 Extended Involved Site Radiation Therapy and Target volumes; 3.7.3 Radiation Delivery; 3.7.4 Dose and Fractionation; 3.8 Outcomes; 3.8.1 Survival; 3.8.2 Failure Patterns |
|
3.9 Toxicity3.9.1 Acute Toxicity; 3.9.2 Late Toxicity; References; 4: Thyroid Lymphoma; 4.1 Introduction; 4.2 Pathology; 4.3 Lymphoma Subtype for Radiation Therapy; 4.4 Pretreatment Evaluation and Staging; 4.5 Prognostic Factors; 4.6 Treatment Strategy; 4.6.1 DLBCL; 4.6.2 MALT; 4.7 Radiation Therapy; 4.7.1 Planning CT; 4.7.2 Gross Tumor Volume (GTV); 4.7.3 Clinical Target Volume (CTV) and Planning Target Volume (PTV); 4.7.4 Dose; 4.7.5 Radiation Therapy Techniques; 4.8 Outcomes; 4.9 Toxicity; References; 5: Pyothorax-Associated Lymphoma; 5.1 Etiology and Pathology |
Summary |
This book is devoted to sharing the knowledge and experience of expert radiation therapy (RT) for extranodal lymphomas. For that purpose, the authors provide clinical-pathological information, precise RT techniques, and treatment results, i.e., disease control and survival, of all extranodal lymphomas. Over the past 10 years, specific techniques have been updated, from 3-dimensional conformal RT to intensity modulated RT / volumetric-modulated arc therapy. Precise targeting such as image-guided RT and active breathing control are now capable of treating lymphoma lesions that shift with respiration or peristalsis. This book, serving as a guide, provides the necessary knowledge for radiation oncology, practice, and planning involving the RT techniques of treating extranodal lymphomas. In addition, it equips oncologists, hematologists, and medical oncologists to refer patients with extranodal lymphomas to radiation oncologists for appropriate treatment in a timely manner. Therefore this volume will greatly benefit all oncologists, including radiation and medical oncologists, as well as hematologists |
Bibliography |
Includes bibliographical references |
Notes |
Vendor-supplied metadata |
Subject |
Lymphomas.
|
|
Lymphomas -- Treatment
|
|
Radiotherapy.
|
|
Lymphoma -- radiotherapy
|
|
Lymphoma
|
|
Radiotherapy
|
|
HEALTH & FITNESS -- Diseases -- General.
|
|
MEDICAL -- Clinical Medicine.
|
|
MEDICAL -- Diseases.
|
|
MEDICAL -- Evidence-Based Medicine.
|
|
MEDICAL -- Internal Medicine.
|
|
Lymphomas
|
|
Lymphomas -- Treatment
|
|
Radiotherapy
|
Form |
Electronic book
|
Author |
Sasai, Keisuke, editor
|
|
Oguchi, Masahiko, editor
|
ISBN |
9784431564355 |
|
4431564357 |
|